These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11925312)

  • 1. Serotonin syndrome and atypical antipsychotics.
    Duggal HS; Fetchko J
    Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizures caused by possible interaction between olanzapine and clomipramine.
    Deshauer D; Albuquerque J; Alda M; Grof P
    J Clin Psychopharmacol; 2000 Apr; 20(2):283-4. PubMed ID: 10770480
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

  • 4. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
    Steele D; Keltner NL; McGuiness TM
    Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
    [No Abstract]   [Full Text] [Related]  

  • 5. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
    Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
    J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
    Schmitt A; Braus DF
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive use of olanzapine in mood disorders: five case reports.
    Weisler RH; Ahearn EP; Davidson JR; Wallace CD
    Ann Clin Psychiatry; 1997 Dec; 9(4):259-62. PubMed ID: 9511951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 36-Year-old woman with loss of consciousness, fever, and tachycardia.
    Freeman WD; Chabolla DR
    Mayo Clin Proc; 2005 May; 80(5):667-70. PubMed ID: 15887435
    [No Abstract]   [Full Text] [Related]  

  • 11. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome with mirtazapine-fluoxetine combination.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):495-6. PubMed ID: 9695042
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine-induced manic-like syndrome.
    Lindenmayer JP; Klebanov R
    J Clin Psychiatry; 1998 Jun; 59(6):318-9. PubMed ID: 9671347
    [No Abstract]   [Full Text] [Related]  

  • 15. Mirtazapine and hyperpigmentation.
    Mendhekar D; Inamdar A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
    [No Abstract]   [Full Text] [Related]  

  • 16. Status epilepticus in a patient treated with olanzapine and mirtazapine.
    Spyridi S; Sokolaki S; Nimatoudis J; Iacovides A; Kaprinis G
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):120-3. PubMed ID: 19203568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine for excessive masturbation in an adolescent with autism.
    Nguyen M; Murphy T
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):868-9. PubMed ID: 11501682
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirtazapine: unable to induce serotonin toxicity?
    Gillman PK
    Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
    Isbister GK; Whyte IM
    Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.